Taiwan FDA registration 3a8e76327d50d216a63d3757825b5821

"Haifeng Biomedical" Rivaroxaban quality control liquid group

TW: “海奉生物醫學”Rivaroxaban品管液組

Taiwan·Risk Class 2·HYPHEN BioMed·Registered Jan 06, 2021 – Jan 06, 2026Expired

Registration details

Analysis ID: 3a8e76327d50d216a63d3757825b5821
Customs Code: DHA05603418503

Company information

Manufacturer: HYPHEN BioMed
Manufacturer Country: France
Authorized Representative: SYSMEX TAIWAN CO., LTD.

Product details

Intended Use: This product contains different concentrations of Rivaroxaban lyophilized human plasma for quality control of Rivaroxaban measurement.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1660 Quality control materials (analytical and non-analytical)
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Jan 06, 2021
Expiry Date: Jan 06, 2026

About this record

Access comprehensive regulatory information for "Haifeng Biomedical" Rivaroxaban quality control liquid group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3a8e76327d50d216a63d3757825b5821 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.